Business Context and Reporting Period
This Form 8-K Current Report was filed by Becton, Dickinson and Company (BD) on June 6, 2006. The filing addresses a specific legal event under Item 8.01 (Other Events) and does not cover a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the disclosure of a legal proceeding and contains no financial statements or operational metrics.
Material Changes
The material change disclosed is the initiation of litigation against BD. On June 6, 2006, UltiMed, Inc. filed a lawsuit in the United States District Court in Minneapolis, Minnesota (Case No. 06CV2266). The plaintiff alleges that BD violated federal and state antitrust laws by entering into anticompetitive contracts that excluded UltiMed from the home use insulin syringe market.
Outlook, Risks, and Management Commentary
- Legal Risk: The plaintiff seeks money damages in an undisclosed amount and injunctive relief.
- Management Response: BD states it believes it has meritorious defenses to the claims and intends to defend the lawsuit vigorously.
- Unusual Items: The filing contains no other unusual items, guidance, or forward-looking financial commentary.
Investor Verification Checklist
- Verify the current status of the UltiMed, Inc. v. Becton, Dickinson and Company litigation (06CV2266).
- Monitor future filings for any updates regarding the potential financial impact or settlement of the antitrust claims.
- Review BD's quarterly and annual reports for any subsequent accruals or disclosures related to this legal contingency.